PMOS: Global Rename Highlights Multisystem Nature of PCOS
A global consensus study published in The Lancet renames polycystic ovary syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its multisystem endocrine, metabolic, reproductive, dermatological and psychological effects. The change aims to update clinical guidelines, medical education, and international disease classifications, enabling earlier diagnosis, holistic patient-centered care, reduced fertility-related stigma, and expanded research into metabolic and systemic impacts.
